Device Trial Radar · NCT02738112
Hyoid Suspension to the Mandible for the Treatment of Obstructive Sleep Apnea
Last checked: Nov 19, 2026Latest source record: Jun 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
Mar 2016
Primary completion
Mar 2019
Study completion Jun 2019
Sponsor
- Lead sponsor
- Abidin, Michael, M.D.Individual
- Sponsor type
- Individual
- First posted
- Apr 14, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hyo-mandibular suspension has been previously studied as a treatment for obstructive sleep apnea (OSA) and has shown to be highly effective. This is a prospective, multi-center, registry during which 30 subjects with OSA will be considered for hyo-mandubular suspension treatment. After obtaining informed consent and meeting all inclusions and exclusion criteria, subjects will be treated using the Encore System. Subject follow-up with the physician or nurse will occur at one (1) week, one (1) month, three (3) months, and twelve (12) months. This study will assess the effectiveness of hyoid suspension in reducing the apnea-hypopnea index (AHI), and improving the Epworth Sleepiness Scale (ESS), snoring (VAS) and functional outcome (FOSQ) for the treatment of obstructive sleep apnea (OSA). In addition, the study will evaluate the effect that the change in hyoid position has on the airway anatomy.
Conditions
- Obstructive Sleep Apnea
Interventions
Encore SystemDevice
Hyo-mandibular suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Apnea-Hypopnea Index (AHI)Time frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Michael Abidin
Alexandria, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.